Exchange Traded Concepts, LLC Novo Cure LTD Transaction History

Exchange Traded Concepts, LLC

$4.74 Billion
Q4 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 28,811 shares of NVCR stock, worth $641,044. This represents 0.02% of its overall portfolio holdings.

Number of Shares

28,811

Previous 48,427 40.51%

Holding current value

$641,044

Previous $756,000 13.49%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$14.54 - $33.41 $285,216 - $655,370	-19,616 Reduced 40.51%	28,811 $858,000
Q3 2024 Oct 10, 2024	BUY	$15.61 - $23.34 $129,125 - $193,068	8,272 Added 20.6%	48,427 $756,000
Q2 2024 Aug 13, 2024	SELL	$11.83 - $24.05 $222,108 - $451,538	-18,775 Reduced 31.86%	40,155 $687,000
Q1 2024 Apr 15, 2024	SELL	$12.42 - $17.29 $184,176 - $256,393	-14,829 Reduced 20.1%	58,930 $921,000
Q4 2023 Jan 05, 2024	BUY	$11.13 - $15.78 $251,838 - $357,054	22,627 Added 44.25%	73,759 $1.1 Million
Q3 2023 Oct 18, 2023	BUY	$16.15 - $42.35 $553,767 - $1.45 Million	34,289 Added 203.58%	51,132 $825,000
Q2 2023 Jul 20, 2023	SELL	$40.29 - $82.51 $39,605 - $81,107	-983 Reduced 5.51%	16,843 $698,000
Q1 2023 Apr 12, 2023	SELL	$56.44 - $118.81 $16,875 - $35,524	-299 Reduced 1.65%	17,826 $1.07 Million
Q4 2022 Jan 17, 2023	BUY	$63.98 - $85.37 $23,544 - $31,416	368 Added 2.07%	18,125 $1.33 Million
Q3 2022 Oct 07, 2022	SELL	$67.99 - $89.57 $278,011 - $366,251	-4,089 Reduced 18.72%	17,757 $1.35 Million
Q2 2022 Jul 20, 2022	SELL	$56.6 - $89.9 $576,697 - $915,991	-10,189 Reduced 31.81%	21,846 $1.52 Million
Q1 2022 Apr 26, 2022	SELL	$60.15 - $84.52 $169,983 - $238,853	-2,826 Reduced 8.11%	32,035 $2.65 Million
Q4 2021 Jan 13, 2022	BUY	$75.08 - $121.99 $1.58 Million - $2.56 Million	20,985 Added 151.23%	34,861 $2.62 Million
Q3 2021 Oct 18, 2021	BUY	$116.17 - $194.55 $373,486 - $625,478	3,215 Added 30.16%	13,876 $1.61 Million
Q2 2021 Jul 30, 2021	SELL	$130.4 - $225.58 $326,652 - $565,077	-2,505 Reduced 19.03%	10,661 $2.37 Million
Q1 2021 Apr 20, 2021	BUY	$124.11 - $190.17 $724,430 - $1.11 Million	5,837 Added 79.64%	13,166 $1.74 Million
Q4 2020 Jan 19, 2021	SELL	$112.16 - $174.14 $223,983 - $347,757	-1,997 Reduced 21.41%	7,329 $1.27 Million
Q3 2020 Oct 30, 2020	BUY	$58.05 - $111.31 $190,520 - $365,319	3,282 Added 54.3%	9,326 $1.04 Million
Q2 2020 Jul 15, 2020	BUY	$57.2 - $74.41 $249,964 - $325,171	4,370 Added 261.05%	6,044 $358,000
Q1 2020 Apr 14, 2020	BUY	$57.05 - $95.75 $62,926 - $105,612	1,103 Added 193.17%	1,674 $113,000
Q4 2019 Jan 22, 2020	BUY	$68.3 - $93.8 $38,999 - $53,559	571 New	571 $48,000

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

73.8M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.34B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Novo Cure LTD Transaction History